Candida auris is an emerging fungus which CDC has indicated presents a potential global threat.  Candida auris was originally identified in Japan in 2009 and in the ensuing 8 years has been identified in multiple other countries, including the United States.  As of September, 2017, greater than 150 infections had been identified in the United States with most infections identified from isolating the organism from a blood culture.

In this presentation Dr. Daly discusses the difficulties in diagnosing and treating this pathogen. Click the image below to view this informative video that runs around 6 minutes.

About The Author

Prior to his role as Chief Medical Officer at COLA, Dr. John Daly was the Director of Clinical Laboratories for the Duke University Health System from 2005-2009. A longtime resident of Durham, NC, Dr. Daly was quite active in the local medical community, joining the staffs of three area hospitals and serving as a member of various hospital committees. He earned his M. D. at Cornell University Medical College, and performed his internship and residency in pathology at Duke University Medical Center. He also is a veteran of the U. S. Navy.

Related Posts

Send this to a friend